Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib

Ana Ursula Gavric, Janja Ocvirk, Polona Jaki Mekjavic
  • Radiology and Oncology, January 2018, De Gruyter
  • DOI: 10.2478/raon-2018-0002
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.2478/raon-2018-0002

In partnership with: